nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefotaxime—SLC22A11—Conjugated Estrogens—osteoporosis	0.219	0.296	CbGbCtD
Cefotaxime—SLC22A11—Estradiol—osteoporosis	0.193	0.26	CbGbCtD
Cefotaxime—SLC22A8—Conjugated Estrogens—osteoporosis	0.128	0.172	CbGbCtD
Cefotaxime—SLC22A8—Estradiol—osteoporosis	0.112	0.151	CbGbCtD
Cefotaxime—SLC22A6—Conjugated Estrogens—osteoporosis	0.0888	0.12	CbGbCtD
Cefotaxime—Pain—Ergocalciferol—osteoporosis	0.00111	0.00427	CcSEcCtD
Cefotaxime—Haemoglobin—Calcitriol—osteoporosis	0.00111	0.00426	CcSEcCtD
Cefotaxime—Haemorrhage—Calcitriol—osteoporosis	0.0011	0.00424	CcSEcCtD
Cefotaxime—Erythema multiforme—Alendronate—osteoporosis	0.00109	0.0042	CcSEcCtD
Cefotaxime—Bronchospasm—Pamidronate—osteoporosis	0.00108	0.00417	CcSEcCtD
Cefotaxime—Hypersensitivity—Calcium Acetate—osteoporosis	0.00108	0.00416	CcSEcCtD
Cefotaxime—Angioedema—Etidronic acid—osteoporosis	0.00108	0.00415	CcSEcCtD
Cefotaxime—Leukopenia—Etidronic acid—osteoporosis	0.00106	0.00407	CcSEcCtD
Cefotaxime—Erythema multiforme—Calcitriol—osteoporosis	0.00104	0.00401	CcSEcCtD
Cefotaxime—Pruritus—Calcium Acetate—osteoporosis	0.00104	0.00399	CcSEcCtD
Cefotaxime—Neutropenia—Pamidronate—osteoporosis	0.00103	0.00396	CcSEcCtD
Cefotaxime—Hepatic function abnormal—Estradiol—osteoporosis	0.00103	0.00395	CcSEcCtD
Cefotaxime—Diarrhoea—Calcium Acetate—osteoporosis	0.001	0.00386	CcSEcCtD
Cefotaxime—Discomfort—Etidronic acid—osteoporosis	0.000993	0.00382	CcSEcCtD
Cefotaxime—Bronchospasm—Zoledronate—osteoporosis	0.000989	0.00381	CcSEcCtD
Cefotaxime—Arrhythmia—Calcitriol—osteoporosis	0.000984	0.00379	CcSEcCtD
Cefotaxime—Renal failure—Pamidronate—osteoporosis	0.000965	0.00371	CcSEcCtD
Cefotaxime—Haemoglobin—Ethinyl Estradiol—osteoporosis	0.000956	0.00368	CcSEcCtD
Cefotaxime—Bronchospasm—Conjugated Estrogens—osteoporosis	0.000952	0.00367	CcSEcCtD
Cefotaxime—Haemorrhage—Ethinyl Estradiol—osteoporosis	0.000951	0.00366	CcSEcCtD
Cefotaxime—Neutropenia—Zoledronate—osteoporosis	0.00094	0.00362	CcSEcCtD
Cefotaxime—Ill-defined disorder—Alendronate—osteoporosis	0.000933	0.00359	CcSEcCtD
Cefotaxime—Angioedema—Estropipate—osteoporosis	0.000933	0.00359	CcSEcCtD
Cefotaxime—Vomiting—Calcium Acetate—osteoporosis	0.000933	0.00359	CcSEcCtD
Cefotaxime—Haemoglobin—Risedronate—osteoporosis	0.000932	0.00359	CcSEcCtD
Cefotaxime—Haemorrhage—Risedronate—osteoporosis	0.000927	0.00357	CcSEcCtD
Cefotaxime—Angioedema—Alendronate—osteoporosis	0.000919	0.00354	CcSEcCtD
Cefotaxime—Agranulocytosis—Pamidronate—osteoporosis	0.000916	0.00353	CcSEcCtD
Cefotaxime—Ill-defined disorder—Ibandronate—osteoporosis	0.000908	0.0035	CcSEcCtD
Cefotaxime—Malaise—Alendronate—osteoporosis	0.000907	0.00349	CcSEcCtD
Cefotaxime—Erythema multiforme—Ethinyl Estradiol—osteoporosis	0.000899	0.00346	CcSEcCtD
Cefotaxime—Angioedema—Ibandronate—osteoporosis	0.000895	0.00344	CcSEcCtD
Cefotaxime—Haemoglobin—Pamidronate—osteoporosis	0.000886	0.00341	CcSEcCtD
Cefotaxime—Malaise—Ibandronate—osteoporosis	0.000883	0.0034	CcSEcCtD
Cefotaxime—Renal failure—Zoledronate—osteoporosis	0.000881	0.00339	CcSEcCtD
Cefotaxime—Haemorrhage—Pamidronate—osteoporosis	0.000881	0.00339	CcSEcCtD
Cefotaxime—Nausea—Calcium Acetate—osteoporosis	0.000872	0.00335	CcSEcCtD
Cefotaxime—Renal failure—Conjugated Estrogens—osteoporosis	0.000849	0.00327	CcSEcCtD
Cefotaxime—Discomfort—Alendronate—osteoporosis	0.000846	0.00326	CcSEcCtD
Cefotaxime—Agranulocytosis—Zoledronate—osteoporosis	0.000837	0.00322	CcSEcCtD
Cefotaxime—Anaphylactic shock—Estropipate—osteoporosis	0.000833	0.00321	CcSEcCtD
Cefotaxime—Convulsion—Calcitriol—osteoporosis	0.00083	0.0032	CcSEcCtD
Cefotaxime—Arrhythmia—Risedronate—osteoporosis	0.000828	0.00319	CcSEcCtD
Cefotaxime—Discomfort—Ibandronate—osteoporosis	0.000824	0.00317	CcSEcCtD
Cefotaxime—Discomfort—Calcitriol—osteoporosis	0.000806	0.0031	CcSEcCtD
Cefotaxime—Anaphylactic shock—Ibandronate—osteoporosis	0.000799	0.00308	CcSEcCtD
Cefotaxime—Shock—Raloxifene—osteoporosis	0.000794	0.00306	CcSEcCtD
Cefotaxime—Feeling abnormal—Etidronic acid—osteoporosis	0.000794	0.00305	CcSEcCtD
Cefotaxime—Thrombocytopenia—Raloxifene—osteoporosis	0.00079	0.00304	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Etidronic acid—osteoporosis	0.000788	0.00303	CcSEcCtD
Cefotaxime—Shock—Ibandronate—osteoporosis	0.000786	0.00303	CcSEcCtD
Cefotaxime—Anaphylactic shock—Calcitriol—osteoporosis	0.000782	0.00301	CcSEcCtD
Cefotaxime—Nausea—Ergocalciferol—osteoporosis	0.00077	0.00296	CcSEcCtD
Cefotaxime—Ill-defined disorder—Ethinyl Estradiol—osteoporosis	0.000768	0.00296	CcSEcCtD
Cefotaxime—Urticaria—Etidronic acid—osteoporosis	0.000765	0.00294	CcSEcCtD
Cefotaxime—Bronchospasm—Estradiol—osteoporosis	0.000762	0.00293	CcSEcCtD
Cefotaxime—Abdominal pain—Etidronic acid—osteoporosis	0.000761	0.00293	CcSEcCtD
Cefotaxime—Angioedema—Ethinyl Estradiol—osteoporosis	0.000756	0.00291	CcSEcCtD
Cefotaxime—Malaise—Ethinyl Estradiol—osteoporosis	0.000746	0.00287	CcSEcCtD
Cefotaxime—Angioedema—Risedronate—osteoporosis	0.000737	0.00284	CcSEcCtD
Cefotaxime—Erythema multiforme—Conjugated Estrogens—osteoporosis	0.000733	0.00282	CcSEcCtD
Cefotaxime—Arrhythmia—Zoledronate—osteoporosis	0.000719	0.00277	CcSEcCtD
Cefotaxime—Pain—Estropipate—osteoporosis	0.000713	0.00274	CcSEcCtD
Cefotaxime—Ill-defined disorder—Pamidronate—osteoporosis	0.000712	0.00274	CcSEcCtD
Cefotaxime—Hypersensitivity—Etidronic acid—osteoporosis	0.00071	0.00273	CcSEcCtD
Cefotaxime—Pain—Alendronate—osteoporosis	0.000702	0.0027	CcSEcCtD
Cefotaxime—Angioedema—Pamidronate—osteoporosis	0.000701	0.0027	CcSEcCtD
Cefotaxime—Discomfort—Ethinyl Estradiol—osteoporosis	0.000696	0.00268	CcSEcCtD
Cefotaxime—Arrhythmia—Conjugated Estrogens—osteoporosis	0.000692	0.00266	CcSEcCtD
Cefotaxime—Malaise—Pamidronate—osteoporosis	0.000692	0.00266	CcSEcCtD
Cefotaxime—Pain—Raloxifene—osteoporosis	0.00069	0.00266	CcSEcCtD
Cefotaxime—Leukopenia—Pamidronate—osteoporosis	0.000687	0.00264	CcSEcCtD
Cefotaxime—Pain—Ibandronate—osteoporosis	0.000683	0.00263	CcSEcCtD
Cefotaxime—Pruritus—Etidronic acid—osteoporosis	0.000681	0.00262	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Estropipate—osteoporosis	0.000681	0.00262	CcSEcCtD
Cefotaxime—Feeling abnormal—Alendronate—osteoporosis	0.000676	0.0026	CcSEcCtD
Cefotaxime—Jaundice—Estradiol—osteoporosis	0.000674	0.00259	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Alendronate—osteoporosis	0.000671	0.00258	CcSEcCtD
Cefotaxime—Pain—Calcitriol—osteoporosis	0.000669	0.00257	CcSEcCtD
Cefotaxime—Convulsion—Pamidronate—osteoporosis	0.000665	0.00256	CcSEcCtD
Cefotaxime—Urticaria—Estropipate—osteoporosis	0.000662	0.00255	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Raloxifene—osteoporosis	0.00066	0.00254	CcSEcCtD
Cefotaxime—Diarrhoea—Etidronic acid—osteoporosis	0.000659	0.00254	CcSEcCtD
Cefotaxime—Abdominal pain—Estropipate—osteoporosis	0.000659	0.00254	CcSEcCtD
Cefotaxime—Body temperature increased—Estropipate—osteoporosis	0.000659	0.00254	CcSEcCtD
Cefotaxime—Feeling abnormal—Ibandronate—osteoporosis	0.000659	0.00253	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Ibandronate—osteoporosis	0.000653	0.00251	CcSEcCtD
Cefotaxime—Urticaria—Alendronate—osteoporosis	0.000652	0.00251	CcSEcCtD
Cefotaxime—Ill-defined disorder—Zoledronate—osteoporosis	0.00065	0.0025	CcSEcCtD
Cefotaxime—Body temperature increased—Alendronate—osteoporosis	0.000649	0.0025	CcSEcCtD
Cefotaxime—Abdominal pain—Alendronate—osteoporosis	0.000649	0.0025	CcSEcCtD
Cefotaxime—Shock—Risedronate—osteoporosis	0.000648	0.00249	CcSEcCtD
Cefotaxime—Discomfort—Pamidronate—osteoporosis	0.000645	0.00248	CcSEcCtD
Cefotaxime—Angioedema—Zoledronate—osteoporosis	0.00064	0.00246	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Calcitriol—osteoporosis	0.00064	0.00246	CcSEcCtD
Cefotaxime—Abdominal pain—Raloxifene—osteoporosis	0.000638	0.00246	CcSEcCtD
Cefotaxime—Body temperature increased—Raloxifene—osteoporosis	0.000638	0.00246	CcSEcCtD
Cefotaxime—Urticaria—Ibandronate—osteoporosis	0.000635	0.00244	CcSEcCtD
Cefotaxime—Malaise—Zoledronate—osteoporosis	0.000632	0.00243	CcSEcCtD
Cefotaxime—Abdominal pain—Ibandronate—osteoporosis	0.000632	0.00243	CcSEcCtD
Cefotaxime—Body temperature increased—Ibandronate—osteoporosis	0.000632	0.00243	CcSEcCtD
Cefotaxime—Leukopenia—Zoledronate—osteoporosis	0.000627	0.00241	CcSEcCtD
Cefotaxime—Anaphylactic shock—Pamidronate—osteoporosis	0.000626	0.00241	CcSEcCtD
Cefotaxime—Haemoglobin—Estradiol—osteoporosis	0.000623	0.0024	CcSEcCtD
Cefotaxime—Urticaria—Calcitriol—osteoporosis	0.000621	0.00239	CcSEcCtD
Cefotaxime—Haemorrhage—Estradiol—osteoporosis	0.00062	0.00239	CcSEcCtD
Cefotaxime—Hepatitis—Estradiol—osteoporosis	0.00062	0.00239	CcSEcCtD
Cefotaxime—Abdominal pain—Calcitriol—osteoporosis	0.000618	0.00238	CcSEcCtD
Cefotaxime—Body temperature increased—Calcitriol—osteoporosis	0.000618	0.00238	CcSEcCtD
Cefotaxime—Angioedema—Conjugated Estrogens—osteoporosis	0.000616	0.00237	CcSEcCtD
Cefotaxime—Shock—Pamidronate—osteoporosis	0.000616	0.00237	CcSEcCtD
Cefotaxime—Hypersensitivity—Estropipate—osteoporosis	0.000614	0.00236	CcSEcCtD
Cefotaxime—Thrombocytopenia—Pamidronate—osteoporosis	0.000613	0.00236	CcSEcCtD
Cefotaxime—Vomiting—Etidronic acid—osteoporosis	0.000612	0.00236	CcSEcCtD
Cefotaxime—Rash—Etidronic acid—osteoporosis	0.000607	0.00234	CcSEcCtD
Cefotaxime—Convulsion—Zoledronate—osteoporosis	0.000607	0.00234	CcSEcCtD
Cefotaxime—Dermatitis—Etidronic acid—osteoporosis	0.000607	0.00234	CcSEcCtD
Cefotaxime—Hypersensitivity—Alendronate—osteoporosis	0.000605	0.00233	CcSEcCtD
Cefotaxime—Headache—Etidronic acid—osteoporosis	0.000603	0.00232	CcSEcCtD
Cefotaxime—Pruritus—Estropipate—osteoporosis	0.00059	0.00227	CcSEcCtD
Cefotaxime—Discomfort—Zoledronate—osteoporosis	0.000589	0.00227	CcSEcCtD
Cefotaxime—Hypersensitivity—Ibandronate—osteoporosis	0.000589	0.00227	CcSEcCtD
Cefotaxime—Erythema multiforme—Estradiol—osteoporosis	0.000586	0.00226	CcSEcCtD
Cefotaxime—Convulsion—Conjugated Estrogens—osteoporosis	0.000585	0.00225	CcSEcCtD
Cefotaxime—Pruritus—Alendronate—osteoporosis	0.000581	0.00223	CcSEcCtD
Cefotaxime—Hypersensitivity—Calcitriol—osteoporosis	0.000576	0.00222	CcSEcCtD
Cefotaxime—Nausea—Etidronic acid—osteoporosis	0.000572	0.0022	CcSEcCtD
Cefotaxime—Anaphylactic shock—Zoledronate—osteoporosis	0.000572	0.0022	CcSEcCtD
Cefotaxime—Diarrhoea—Estropipate—osteoporosis	0.00057	0.00219	CcSEcCtD
Cefotaxime—Pruritus—Ibandronate—osteoporosis	0.000565	0.00218	CcSEcCtD
Cefotaxime—Pain—Risedronate—osteoporosis	0.000563	0.00217	CcSEcCtD
Cefotaxime—Shock—Zoledronate—osteoporosis	0.000563	0.00217	CcSEcCtD
Cefotaxime—Diarrhoea—Alendronate—osteoporosis	0.000562	0.00216	CcSEcCtD
Cefotaxime—Thrombocytopenia—Zoledronate—osteoporosis	0.00056	0.00215	CcSEcCtD
Cefotaxime—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000557	0.00214	CcSEcCtD
Cefotaxime—Pruritus—Calcitriol—osteoporosis	0.000553	0.00213	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000552	0.00213	CcSEcCtD
Cefotaxime—Diarrhoea—Raloxifene—osteoporosis	0.000552	0.00213	CcSEcCtD
Cefotaxime—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000551	0.00212	CcSEcCtD
Cefotaxime—Diarrhoea—Ibandronate—osteoporosis	0.000547	0.0021	CcSEcCtD
Cefotaxime—Shock—Conjugated Estrogens—osteoporosis	0.000542	0.00208	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Risedronate—osteoporosis	0.000539	0.00207	CcSEcCtD
Cefotaxime—Urticaria—Ethinyl Estradiol—osteoporosis	0.000537	0.00207	CcSEcCtD
Cefotaxime—Pain—Pamidronate—osteoporosis	0.000535	0.00206	CcSEcCtD
Cefotaxime—Diarrhoea—Calcitriol—osteoporosis	0.000535	0.00206	CcSEcCtD
Cefotaxime—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000534	0.00205	CcSEcCtD
Cefotaxime—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000534	0.00205	CcSEcCtD
Cefotaxime—Vomiting—Estropipate—osteoporosis	0.00053	0.00204	CcSEcCtD
Cefotaxime—Rash—Estropipate—osteoporosis	0.000525	0.00202	CcSEcCtD
Cefotaxime—Dermatitis—Estropipate—osteoporosis	0.000525	0.00202	CcSEcCtD
Cefotaxime—Urticaria—Risedronate—osteoporosis	0.000523	0.00201	CcSEcCtD
Cefotaxime—Headache—Estropipate—osteoporosis	0.000522	0.00201	CcSEcCtD
Cefotaxime—Vomiting—Alendronate—osteoporosis	0.000522	0.00201	CcSEcCtD
Cefotaxime—Body temperature increased—Risedronate—osteoporosis	0.000521	0.002	CcSEcCtD
Cefotaxime—Abdominal pain—Risedronate—osteoporosis	0.000521	0.002	CcSEcCtD
Cefotaxime—Rash—Alendronate—osteoporosis	0.000518	0.00199	CcSEcCtD
Cefotaxime—Dermatitis—Alendronate—osteoporosis	0.000517	0.00199	CcSEcCtD
Cefotaxime—Feeling abnormal—Pamidronate—osteoporosis	0.000516	0.00199	CcSEcCtD
Cefotaxime—Headache—Alendronate—osteoporosis	0.000514	0.00198	CcSEcCtD
Cefotaxime—Vomiting—Raloxifene—osteoporosis	0.000513	0.00198	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Pamidronate—osteoporosis	0.000512	0.00197	CcSEcCtD
Cefotaxime—Rash—Raloxifene—osteoporosis	0.000509	0.00196	CcSEcCtD
Cefotaxime—Dermatitis—Raloxifene—osteoporosis	0.000508	0.00196	CcSEcCtD
Cefotaxime—Vomiting—Ibandronate—osteoporosis	0.000508	0.00196	CcSEcCtD
Cefotaxime—Headache—Raloxifene—osteoporosis	0.000506	0.00195	CcSEcCtD
Cefotaxime—Rash—Ibandronate—osteoporosis	0.000504	0.00194	CcSEcCtD
Cefotaxime—Dermatitis—Ibandronate—osteoporosis	0.000503	0.00194	CcSEcCtD
Cefotaxime—Ill-defined disorder—Estradiol—osteoporosis	0.000501	0.00193	CcSEcCtD
Cefotaxime—Headache—Ibandronate—osteoporosis	0.000501	0.00193	CcSEcCtD
Cefotaxime—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000498	0.00192	CcSEcCtD
Cefotaxime—Vomiting—Calcitriol—osteoporosis	0.000497	0.00191	CcSEcCtD
Cefotaxime—Nausea—Estropipate—osteoporosis	0.000495	0.0019	CcSEcCtD
Cefotaxime—Abdominal pain—Pamidronate—osteoporosis	0.000495	0.0019	CcSEcCtD
Cefotaxime—Body temperature increased—Pamidronate—osteoporosis	0.000495	0.0019	CcSEcCtD
Cefotaxime—Angioedema—Estradiol—osteoporosis	0.000493	0.0019	CcSEcCtD
Cefotaxime—Rash—Calcitriol—osteoporosis	0.000493	0.0019	CcSEcCtD
Cefotaxime—Dermatitis—Calcitriol—osteoporosis	0.000493	0.0019	CcSEcCtD
Cefotaxime—Headache—Calcitriol—osteoporosis	0.00049	0.00189	CcSEcCtD
Cefotaxime—Pain—Zoledronate—osteoporosis	0.000489	0.00188	CcSEcCtD
Cefotaxime—Nausea—Alendronate—osteoporosis	0.000488	0.00188	CcSEcCtD
Cefotaxime—Malaise—Estradiol—osteoporosis	0.000487	0.00187	CcSEcCtD
Cefotaxime—Hypersensitivity—Risedronate—osteoporosis	0.000485	0.00187	CcSEcCtD
Cefotaxime—Nausea—Raloxifene—osteoporosis	0.000479	0.00185	CcSEcCtD
Cefotaxime—Pruritus—Ethinyl Estradiol—osteoporosis	0.000478	0.00184	CcSEcCtD
Cefotaxime—Nausea—Ibandronate—osteoporosis	0.000475	0.00183	CcSEcCtD
Cefotaxime—Feeling abnormal—Zoledronate—osteoporosis	0.000471	0.00181	CcSEcCtD
Cefotaxime—Pain—Conjugated Estrogens—osteoporosis	0.000471	0.00181	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Zoledronate—osteoporosis	0.000468	0.0018	CcSEcCtD
Cefotaxime—Pruritus—Risedronate—osteoporosis	0.000466	0.00179	CcSEcCtD
Cefotaxime—Nausea—Calcitriol—osteoporosis	0.000465	0.00179	CcSEcCtD
Cefotaxime—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000462	0.00178	CcSEcCtD
Cefotaxime—Hypersensitivity—Pamidronate—osteoporosis	0.000461	0.00178	CcSEcCtD
Cefotaxime—Urticaria—Zoledronate—osteoporosis	0.000454	0.00175	CcSEcCtD
Cefotaxime—Discomfort—Estradiol—osteoporosis	0.000454	0.00175	CcSEcCtD
Cefotaxime—Abdominal pain—Zoledronate—osteoporosis	0.000452	0.00174	CcSEcCtD
Cefotaxime—Body temperature increased—Zoledronate—osteoporosis	0.000452	0.00174	CcSEcCtD
Cefotaxime—Diarrhoea—Risedronate—osteoporosis	0.000451	0.00173	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.00045	0.00173	CcSEcCtD
Cefotaxime—Pruritus—Pamidronate—osteoporosis	0.000443	0.0017	CcSEcCtD
Cefotaxime—Anaphylactic shock—Estradiol—osteoporosis	0.000441	0.0017	CcSEcCtD
Cefotaxime—Urticaria—Conjugated Estrogens—osteoporosis	0.000437	0.00168	CcSEcCtD
Cefotaxime—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000435	0.00168	CcSEcCtD
Cefotaxime—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000435	0.00168	CcSEcCtD
Cefotaxime—Shock—Estradiol—osteoporosis	0.000434	0.00167	CcSEcCtD
Cefotaxime—Vomiting—Ethinyl Estradiol—osteoporosis	0.000429	0.00165	CcSEcCtD
Cefotaxime—Diarrhoea—Pamidronate—osteoporosis	0.000428	0.00165	CcSEcCtD
Cefotaxime—Rash—Ethinyl Estradiol—osteoporosis	0.000426	0.00164	CcSEcCtD
Cefotaxime—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000425	0.00164	CcSEcCtD
Cefotaxime—Headache—Ethinyl Estradiol—osteoporosis	0.000423	0.00163	CcSEcCtD
Cefotaxime—Hypersensitivity—Zoledronate—osteoporosis	0.000421	0.00162	CcSEcCtD
Cefotaxime—Vomiting—Risedronate—osteoporosis	0.000419	0.00161	CcSEcCtD
Cefotaxime—Rash—Risedronate—osteoporosis	0.000415	0.0016	CcSEcCtD
Cefotaxime—Dermatitis—Risedronate—osteoporosis	0.000415	0.0016	CcSEcCtD
Cefotaxime—Headache—Risedronate—osteoporosis	0.000413	0.00159	CcSEcCtD
Cefotaxime—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000406	0.00156	CcSEcCtD
Cefotaxime—Pruritus—Zoledronate—osteoporosis	0.000405	0.00156	CcSEcCtD
Cefotaxime—Nausea—Ethinyl Estradiol—osteoporosis	0.000401	0.00154	CcSEcCtD
Cefotaxime—Vomiting—Pamidronate—osteoporosis	0.000398	0.00153	CcSEcCtD
Cefotaxime—Rash—Pamidronate—osteoporosis	0.000395	0.00152	CcSEcCtD
Cefotaxime—Dermatitis—Pamidronate—osteoporosis	0.000394	0.00152	CcSEcCtD
Cefotaxime—Headache—Pamidronate—osteoporosis	0.000392	0.00151	CcSEcCtD
Cefotaxime—Diarrhoea—Zoledronate—osteoporosis	0.000391	0.00151	CcSEcCtD
Cefotaxime—Nausea—Risedronate—osteoporosis	0.000391	0.00151	CcSEcCtD
Cefotaxime—Pruritus—Conjugated Estrogens—osteoporosis	0.00039	0.0015	CcSEcCtD
Cefotaxime—Pain—Estradiol—osteoporosis	0.000377	0.00145	CcSEcCtD
Cefotaxime—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000377	0.00145	CcSEcCtD
Cefotaxime—Nausea—Pamidronate—osteoporosis	0.000372	0.00143	CcSEcCtD
Cefotaxime—Vomiting—Zoledronate—osteoporosis	0.000364	0.0014	CcSEcCtD
Cefotaxime—Feeling abnormal—Estradiol—osteoporosis	0.000363	0.0014	CcSEcCtD
Cefotaxime—Rash—Zoledronate—osteoporosis	0.000361	0.00139	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Estradiol—osteoporosis	0.00036	0.00139	CcSEcCtD
Cefotaxime—Dermatitis—Zoledronate—osteoporosis	0.00036	0.00139	CcSEcCtD
Cefotaxime—Headache—Zoledronate—osteoporosis	0.000358	0.00138	CcSEcCtD
Cefotaxime—Vomiting—Conjugated Estrogens—osteoporosis	0.00035	0.00135	CcSEcCtD
Cefotaxime—Urticaria—Estradiol—osteoporosis	0.00035	0.00135	CcSEcCtD
Cefotaxime—Body temperature increased—Estradiol—osteoporosis	0.000348	0.00134	CcSEcCtD
Cefotaxime—Abdominal pain—Estradiol—osteoporosis	0.000348	0.00134	CcSEcCtD
Cefotaxime—Rash—Conjugated Estrogens—osteoporosis	0.000347	0.00134	CcSEcCtD
Cefotaxime—Dermatitis—Conjugated Estrogens—osteoporosis	0.000347	0.00133	CcSEcCtD
Cefotaxime—Headache—Conjugated Estrogens—osteoporosis	0.000345	0.00133	CcSEcCtD
Cefotaxime—Nausea—Zoledronate—osteoporosis	0.00034	0.00131	CcSEcCtD
Cefotaxime—Nausea—Conjugated Estrogens—osteoporosis	0.000327	0.00126	CcSEcCtD
Cefotaxime—Hypersensitivity—Estradiol—osteoporosis	0.000325	0.00125	CcSEcCtD
Cefotaxime—Pruritus—Estradiol—osteoporosis	0.000312	0.0012	CcSEcCtD
Cefotaxime—Diarrhoea—Estradiol—osteoporosis	0.000302	0.00116	CcSEcCtD
Cefotaxime—Vomiting—Estradiol—osteoporosis	0.00028	0.00108	CcSEcCtD
Cefotaxime—Rash—Estradiol—osteoporosis	0.000278	0.00107	CcSEcCtD
Cefotaxime—Dermatitis—Estradiol—osteoporosis	0.000278	0.00107	CcSEcCtD
Cefotaxime—Headache—Estradiol—osteoporosis	0.000276	0.00106	CcSEcCtD
Cefotaxime—Nausea—Estradiol—osteoporosis	0.000262	0.00101	CcSEcCtD
